课题基金 / 基金详情

Engineering peptide-MHC/co-stimulator-based nanoparticle vaccines for the treatment of metastatic cancer

Engineering peptide-MHC/co-stimulator-based nanoparticle vaccines for the treatment of metastatic cancer
用于治疗转移性癌症的工程肽-MHC/共刺激剂纳米颗粒疫苗
批准号：
335866
负责人：
Shao Kun
金额：
$10.2万
依托单位：
University of Calgary
依托单位国家：
加拿大
项目类别：
Fellowship Programs
财政年份：
2015
资助国家：
加拿大
项目状态：
已结题
起止时间：
2015-09-01 至 2017-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=335866&lang=en
关键词：
Biomaterials Bionanomedicines Cancer Immunotherapy Co-Stimulatory Molecules Metastatic Cancer Nanovaccines Peptide-Major Histocompatibility Complexes

项目摘要

项目成果

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cancer is the leading cause of death in the world. Although the last decade has witnessed significant advances in the treatment of cancer, most cancers remain incurable, making this disorder an ongoing huge health care challenge for governments worldwide.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文